Intervention

Bevacizumab Injection

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung CancerNCT06512051 · 2024-07-30

Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic RetinopathyNCT04674254 · 2021-03-30

Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver GeneNCT03905317 · 2019-03-01

Common conditions

Advanced or Metastatic Non-small Cell Lung Cancer1 Diabetic Retinopathy1 Lung Adenocarcinoma1 Proliferative Diabetic Retinopathy1 Vascular Endothelial Growth Factor Overexpression1

Leading sponsors

Cairo University1 Shanghai Hengrui Pharmaceutical Co., Ltd.1 Sun Yat-sen University1

Trial status mix

COMPLETED1

RECRUITING1

UNKNOWN1

Phase mix

PHASE22

PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.